bromodeoxyuridine has been researched along with trientine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DP; Chin-Sinex, H; Mendonca, MS; Nie, B; Wang, M | 1 |
1 other study(ies) available for bromodeoxyuridine and trientine
| Article | Year |
|---|---|
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer.
Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Cisplatin; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ovarian Neoplasms; Superoxide Dismutase; Superoxide Dismutase-1; Trientine; Tumor Stem Cell Assay | 2009 |